As a business strategy consultant I provide quantitative data to guide business decisions for pre-launch to post-marketing pharmaceutical products. I work on providing clients with a wide variety of data including scientific information on disease background, current treatment paradigm, and analysis of clinical trials. I also design and interpret analyses on large insurance claim databases (such as PharMetrics) to better understand the competitive environment and market dynamics in a therapeutic area. I use primary data derived from market research to fill in gaps and provide further insight into a disease area. • Independently identifed/designed analytic tasks and contributed to the development of the overall analytic framework for consulting projects• Designed databases for analysis and generated visualizations using software programs such as PowerBI and Tableau• Drafted and completed reports, presentations, and disease area handbooks• Contributed to project planning and budget management efforts• Provided training and technical supervision to less-experienced staff, including reviewing their analyses and providing coaching and direction

Designed and developed new assays to understand at a molecular level how epithelial cell polarity cross talks with innate immunity, specifically how this pathway is regulated in the context of Cystic Fibrosis. Discovered that proteins that are involved with establishing and maintaining cell polarity function to rapidly remodel host cell membranes following pathogen binding, and that this change can activate the innate immune response. •Developed a novel assay and experimental system to rapidly target proteins to the apical membrane of polarized cells using chemically induced dimerization•Used molecular biology tools to design and implement expression systems for chimeric proteins •Extensively used retroviruses and lentiviruses to make stable cell lines•Utilized quantitative microscopy to understand how morphological changes in epithelial cells are related to activation of the innate immune system •Utilized primary human bronchial epithelial cell cultures to understand the innate immune response•Featured researcher in the 2014 Cystic Fibrosis Research, Inc. Fundamentals video series (http://bit.ly/1yQd3Ul)

Applied both classical and state-of-the-art methods to understand how the coronavirus E protein is able to perform multiple roles during infection. Demonstrated that the E protein adopts two distinct membrane topologies (a hairpin and a transmembrane form) that serve to either drive virion formation or alter the host secretory pathway to the advantage of the virus. •Utilized classical trafficking assays combined with modern cDNA expression systems and cell culture models of viral infection•Used modern and classical virology techniques to characterize coronavirus assembly and release from infected cells•Employed quantitative imaging to analyze changes in organelle structure and function•Extensively used molecular cloning to design and express chimeric proteins•Actively sought collaborations that led to co-authored publications in diverse fields including quantitative mass spectrometry, protein structure, and metabolism

Worked in a team that was responsible for analyzing the purity of synthesized pharmacological compounds to ensure that they met FDA standards. Used teamwork and clear communication to meet testing deadlines.•Performed quality control analysis on manufactured pharmaceutical compounds•Expertise in HPLC, and standard analytical tests and proficient in industry style laboratory documentation